Quantcast

Latest Breakthrough seizure Stories

2014-07-31 16:29:24

AZ-002 Phase 2a Study in Patients with Epilepsy Planned for Second Half of 2014 MOUNTAIN VIEW, Calif., July 31, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its pipeline and new product development efforts. In the second half of 2014, Alexza expects to initiate a Phase 2a study of AZ-002 (Staccato(®) alprazolam), which is being developed for the management of patients with acute repetitive seizures. Additionally, Alexza has...

2012-02-18 01:45:08

The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy. The U.S. Food and Drug Administration claims generic antiepileptic drugs have the same dosage, purity and strength as their brand-name counterparts and the two are interchangeable. But doctors and people with epilepsy remain concerned, citing widespread reports of individuals suffering seizures after switching...

2011-04-15 08:12:13

By Rhonda Craig, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- A new drug could provide hope for people who suffer from epileptic seizures. The drug, called perampanel, may significantly reduce seizures in people with hard-to-treat epilepsy. More than 2 million Americans suffer from epileptic seizures. The episodes can last anywhere from a few seconds to a few minutes and can greatly disrupt a person's everyday life. However, the first clinical trial to test a 12-milligram dose of the...

2009-05-12 12:09:00

WASHINGTON, May 12 /PRNewswire/ -- The Epilepsy Foundation recently announced findings that show people with epilepsy, whose seizures have been controlled with a consistent drug therapy, have a greater chance of increased seizures, greater side effects or sudden death when their medications are switched from one version of an antiepileptic drug (AED) to another, whether the switch was brand-to-generic, generic-to-brand or generic-to-generic. See video from the Epilepsy Foundation at:...

2008-12-10 10:22:56

A new study reveals it is generally safe to stop anti-seizure medications in children with epilepsy who have been seizure-free while on the treatment. Epilepsy, characterized by the occurrence of two or more seizures, affects more than three million people in the United States. Roughly 10 percent of children with epilepsy have the intractable version, where medications alone cannot control seizures that can disrupt their quality of life. According to Katherine Nickels, M.D., study author and...

2008-10-27 12:00:30

Valeant Pharmaceuticals, a specialty pharmaceutical company, has signed an agreement with GlaxoSmithKline for the promotion of Diastat and Diastat AcuDial, the first and only FDA-approved, acute at-home medication for patients two years and older on stable antiepileptic medications who experience bouts of increased seizure activity, sometimes called serial or cluster seizures or breakthrough seizures. Under the terms of the agreement, GlaxoSmithKline will exclusively promote Diastat and...

2008-10-24 09:00:26

Valeant Pharmaceuticals (NYSE:VRX) today announced that it has signed an agreement with GlaxoSmithKline (NYSE:GSK) for the promotion of Diastat(R) and Diastat(R) AcuDial(TM), the first and only FDA-approved, acute at-home medication for patients two years and older on stable antiepileptic medications (AEDs) who experience bouts of increased seizure activity, sometimes called serial or cluster seizures or breakthrough seizures. Under the terms of the agreement, GSK will exclusively...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related